{"id":"https://openalex.org/W2767319623","doi":"https://doi.org/10.1093/neuonc/nox168.070","title":"ACTR-84. D-TERMINED: A PHASE 1 TRIAL IN NEWLY DIAGNOSED HIGH GRADE GLIOMA WITH TEMOZOLOMIDE, RADIATION, AND MINOCYCLINE FOLLOWED BY ADJUVANT MINOCYCLINE/TEMOZOLOMIDE","display_name":"ACTR-84. D-TERMINED: A PHASE 1 TRIAL IN NEWLY DIAGNOSED HIGH GRADE GLIOMA WITH TEMOZOLOMIDE, RADIATION, AND MINOCYCLINE FOLLOWED BY ADJUVANT MINOCYCLINE/TEMOZOLOMIDE","publication_year":2017,"publication_date":"2017-11-01","ids":{"openalex":"https://openalex.org/W2767319623","doi":"https://doi.org/10.1093/neuonc/nox168.070","mag":"2767319623"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/nox168.070","doi":"https://doi.org/10.1093/neuonc/nox168.070","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/nox168.070","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC5692524","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029624096","display_name":"Adam Louis Cohen","orcid":"https://orcid.org/0000-0002-8541-2287","observed_orcids":["https://orcid.org/0000-0002-8541-2287"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Cohen","raw_affiliation_strings":["Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022531593","display_name":"Karthik Sonty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karthik Sonty","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080895084","display_name":"Randy L. Jensen","orcid":"https://orcid.org/0000-0002-2824-4221","observed_orcids":["https://orcid.org/0000-0002-2824-4221"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Randy Jensen","raw_affiliation_strings":["Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035423539","display_name":"Dennis C. Shrieve","orcid":"https://orcid.org/0000-0002-9212-7249","observed_orcids":["https://orcid.org/0000-0002-9212-7249"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis Shrieve","raw_affiliation_strings":["Department of Radiation Oncology, University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052079848","display_name":"Karen L. Salzman","orcid":"https://orcid.org/0000-0002-3298-6607","observed_orcids":["https://orcid.org/0000-0002-3298-6607"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Salzman","raw_affiliation_strings":["Department of Radiology, University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiology, University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Brett Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brett Johnson","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101639205","display_name":"Melissa L. Thomas","orcid":"https://orcid.org/0000-0003-1843-0933","observed_orcids":["https://orcid.org/0000-0003-1843-0933"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Thomas","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048289311","display_name":"Whitney D. Moss","orcid":"https://orcid.org/0000-0002-7490-6804","observed_orcids":["https://orcid.org/0000-0002-7490-6804"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Whitney Moss","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081148052","display_name":"Amanda Behunin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Behunin","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008224934","display_name":"Elizabeth Prystas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Prystas","raw_affiliation_strings":["Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047608444","display_name":"Howard Colman","orcid":"https://orcid.org/0000-0002-4027-7317","observed_orcids":["https://orcid.org/0000-0002-4027-7317"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard Colman","raw_affiliation_strings":["Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"19","issue":"suppl_6","first_page":"vi19","last_page":"vi19"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11763","display_name":"Intracerebral and Subarachnoid Hemorrhage Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/minocycline","display_name":"minocycline","score":0.9359999895095825},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9620000123977661},{"id":"https://openalex.org/keywords/high-grade-glioma","display_name":"high-grade glioma","score":0.8679999709129333},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9539999961853027},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.8740000128746033},{"id":"https://openalex.org/keywords/microglial-activation","display_name":"microglial activation","score":0.7879999876022339},{"id":"https://openalex.org/keywords/nf-kappab","display_name":"NF-\u03baB","score":0.8740000128746033},{"id":"https://openalex.org/keywords/mesenchymal-phenotype","display_name":"mesenchymal phenotype","score":0.9089999794960022},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.6460000276565552},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6200000047683716},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8379999995231628},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8149999976158142},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5019999742507935},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.44200000166893005},{"id":"https://openalex.org/keywords/blood-brain-barrier-penetration","display_name":"blood-brain barrier penetration","score":0.7129999995231628},{"id":"https://openalex.org/keywords/tetracycline-derivatives","display_name":"tetracycline derivatives","score":0.5320000052452087},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.35100001096725464}],"concepts":[{"id":"https://openalex.org/C2778275353","wikidata":"https://www.wikidata.org/wiki/Q415336","display_name":"Minocycline","level":3,"score":0.9275375604629517},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.9267866611480713},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7757327556610107},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5719410181045532},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.48497796058654785},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.478549063205719},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.41590046882629395},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3929286003112793},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3359437584877014},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33535319566726685},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.2764451503753662},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2094499170780182},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.07351255416870117},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.06508302688598633},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/neuonc/nox168.070","doi":"https://doi.org/10.1093/neuonc/nox168.070","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/nox168.070","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5154346","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5692524","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5692524","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5692524","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:5154346","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5692524","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4395022508","https://openalex.org/W4309017995","https://openalex.org/W3034133456","https://openalex.org/W2589332916","https://openalex.org/W4362593322","https://openalex.org/W1588455244","https://openalex.org/W2063381712","https://openalex.org/W6964621902","https://openalex.org/W2245143108","https://openalex.org/W2718331195"],"abstract_inverted_index":{"Activated":[0],"microglia":[1,38],"in":[2,56,59,256,273],"high":[3,259,275],"grade":[4,85,206,219,260,276],"gliomas":[5],"secrete":[6],"TNF,":[7],"which":[8,22,237],"activates":[9],"NF-kappaB.":[10],"Activation":[11],"of":[12,20,36,42,127,143,178,223,245,264,271,283],"NF-kB":[13],"promotes":[14],"transition":[15],"to":[16,47,61,119,162],"the":[17,49,77,121,141,148,163,168,197,241],"mesenchymal":[18,287],"phenotype":[19,288],"GBM,":[21],"is":[23,32,45,278],"associated":[24],"with":[25,82,90,110,129,252],"increased":[26],"radiation-resistance":[27],"and":[28,40,52,58,123,131,167,209,211,254,286],"poorer":[29],"prognosis.":[30],"Minocycline":[31,44,247],"a":[33,67,91,99],"tetracycline-derivative":[34],"capable":[35],"blocking":[37],"activation":[39,285],"release":[41],"TNF.":[43],"known":[46],"cross":[48],"blood-brain":[50],"barrier":[51],"has":[53],"been":[54],"shown":[55],"vitro":[57],"vivo":[60],"inhibit":[62],"GBM":[63],"proliferation.":[64],"D-TERMINED":[65],"was":[66,138,170,266],"single":[68],"arm,":[69],"open":[70],"label":[71],"phase":[72],"I":[73],"trial":[74],"sponsored":[75],"by":[76,98,140],"Musella":[78],"Foundation":[79],"enrolling":[80],"people":[81,144,213],"newly":[83,257],"diagnosed":[84,258],"3":[86,92,94,207],"or":[87],"4":[88],"glioma":[89,277],"+":[93],"dose":[95,102,164],"escalation":[96,165],"followed":[97],"14":[100],"patient":[101],"expansion":[103],"cohort.":[104],"All":[105,187],"patients":[106,159,180,188,225],"received":[107],"standard":[108],"chemoradiation":[109],"temozolomide":[111,216,255],"plus":[112],"continuous":[113],"oral":[114],"minocycline.":[115],"Primary":[116],"objectives":[117,134],"were":[118,160,181],"define":[120],"MTD":[122,169],"adverse":[124],"event":[125],"rate":[126],"minocycline":[128,272],"radiation":[130,253],"temozolomide;":[132],"secondary":[133],"included":[135],"PFS.":[136],"Efficacy":[137],"assessed":[139],"percent":[142],"whose":[145],"PFS":[146,151],"exceeded":[147,230],"predicted":[149],"median":[150],"based":[152],"on":[153],"RTOG":[154],"RPA":[155],"class.":[156],"Nine":[157],"evaluable":[158],"enrolled":[161],"component,":[166],"defined":[171],"as":[172],"150mg":[173,184,191,198,228],"PO":[174,185,192,199],"BID.":[175,186],"A":[176,262],"total":[177],"20":[179,224],"treated":[182,189,226],"at":[183,190,227],"BID":[193,200,229],"had":[194,205,215],"GBM.":[195],"At":[196],"dose,":[201],"one":[202],"person":[203],"(5%)":[204],"nausea":[208],"dizziness,":[210],"two":[212],"(10%)":[214],"interruptions":[217],"for":[218],"3\u20134":[220],"thrombocytopenia.":[221],"11":[222],"expected":[231],"PFS,":[232],"55%":[233],"(95%":[234],"CI":[235],"32%-77%),":[236],"does":[238],"not":[239,267,279],"meet":[240],"prescribed":[242],"efficacy":[243,265],"endpoint":[244],"70%.":[246],"can":[248],"be":[249],"safely":[250],"combined":[251],"glioma.":[261],"signal":[263],"seen.":[268],"Further":[269],"investigation":[270],"unselected":[274],"warranted,":[280],"though":[281],"biomarkers":[282],"NF-kappaB":[284],"are":[289],"being":[290],"investigated.":[291]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-11-17T00:00:00"}